Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Stericycle Inc    SRCL   US8589121081

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales1 9132 1432 5562 8763 0773 349
Operating income (EBITDA)570645720797909975
Operating profit (EBIT)494556615683798914
Pre-Tax Profit (EBT)417478----
Net income268311326361440-
EPS ( $)3,083,563,794,135,155,80
Dividend per Share ( $)------
Yield------
Announcement Date02/06/2013
09:02pm
02/05/2014
09:02pm
02/05/2015
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt1 3241 3691 6371 2941 052766
Finance------
Operating income (EBITDA)570645720797909975
Leverage
(Debt/EBITDA)
2,32x2,12x2,27x1,62x1,16x0,79x
Capital Expenditure65,273,186,596,698,5113
Book Value Per Share (BVPS)17,9 $20,6 $22,4 $26,8 $29,2 $-
Cash Flow per Share4,45 $4,62 $5,20 $6,22 $7,25 $7,24 $
Announcement Date02/06/2013
09:02pm
02/05/2014
09:02pm
02/05/2015
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 11 254 M$ -
Entreprise Value (EV) 12 548 M$ 12 306 M$
Valuation 2015e 2016e
PER (Price / EPS) 32,1x 25,7x
Capitalization / Revenue 3,91x 3,66x
EV / Revenue 4,36x 4,00x
EV / EBITDA 15,7x 13,5x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 4,94x 4,53x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 23,7% 25,9%
operating Leverage (Delta EBIT / Delta Sales) 0,88x 2,41x
Net Margin (Net Profit / Revenue) 12,6% 14,3%
ROA (Net Profit / Asset) 34,4% 93,0%
ROE (Net Profit / Equities) 17,9% 18,8%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   3,36% 3,20%
Cash Flow / Sales (Taux d'autofinancement) 18,4% 20,0%
Capital Intensity (Assets / Sales) 0,37x 0,15x
Financial Leverage (Net Debt / EBITDA) 1,62x 1,16x
Price Earning Ratio
EPS & Dividend